By:
On:
In: International News
With: 0 Comments

Novavax’ COVID-19 vaccine has been granted emergency use authorization for use in the adolescent population ages 12–18 in India.Novavax, a vaccine development and commercialization company, and Serum Institute of India, the world’s largest vaccine manufacturer by volume, announced on March 22, 2022 that Novavax’ COVID-19 vaccine has been granted emergency use authorization (EUA) for adolescents…Continue Reading

By:
On:
In: International News
With: 0 Comments

Novavax announced on Tuesday (March 22) that the Drugs Controller General of India (DCGI) has granted its coronavirus (COVID-19) vaccine emergency-use authorisation for children aged 12 to 17 years.  In a statement published on its website, the company noted that DCGI has granted emergency use authorisation (EUA) for Novavax jabs for adolescents.  “The vaccine, also…Continue Reading